首页 > 市场调查报告书 > 医疗设备

体外诊断生技设备

分子诊断原料市场规模、份额和成长分析：按产品类型、技术、应用、最终用户和地区划分－2026-2033年产业预测

市场调查报告书

商品编码

1964593

分子诊断原料市场规模、份额和成长分析：按产品类型、技术、应用、最终用户和地区划分－2026-2033年产业预测

Molecular Diagnostics Raw Material Market Size, Share, and Growth Analysis, By Product Type (Nucleic Acids, Primers & Probes), By Technology, By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2026年02月17日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2024年全球分子诊断原料市场价值为35亿美元，预计将从2025年的38亿美元成长到2033年的72.9亿美元。预测期（2026-2033年）的复合年增长率预计为8.5%。

分子诊断原料市场受到对精准快速核酸检测需求激增的显着影响，尤其是在疫情期间公众意识的提高下。酵素、寡核苷酸、探针、缓衝液和特殊塑胶等关键组件对于病原体和遗传标记的检测至关重要。这些原料的品质直接影响检测的敏感度和合规性，而这对于患者预后和公共卫生应对措施至关重要。市场正从传统的PCR试剂向次世代定序等先进应用发展。供应链的韧性和一致的产品标准是关键的成长要素，它们使製造商能够确保可靠的检测能力。这为区域生产和创新（例如稳定试剂）创造了机会，并鼓励投资者专注于垂直整合和认证，以掌握不断增长的市场需求。

全球分子诊断原料市场驱动因素

个人化医疗需求的日益增长显着增加了分子诊断领域对各种高品质原料的需求。由于个人化诊断依赖于特定的试剂、酵素、引子和探针，製造商和实验室都在寻求可靠的组件，这些组件对于开发和检验针对标靶治疗的伴随诊断至关重要。这种需求推动了持续的采购，并促使供应商不断提升自身能力。一致性、纯度和批间可重复性的要求在市场扩张中发挥关键作用，因为这促使企业投资于专业生产技术、品管系统和稳健的供应链，以充分满足临床应用不断变化的需求。

全球分子诊断原料市场限制因素

分子诊断原料市场对复杂且全球互联的供应链的依赖带来了巨大挑战。这些网路的中断、物流障碍以及供应商绩效的波动都可能阻碍关键试剂和组件的稳定供应。当製造商面临采购问题或材料品质不稳定时，会导致检测方法开发和产品上市的延误，最终影响客户信心。此外，不同地区的供应商合格和监管合规要求增加了营运复杂性，并限制了製造商快速回应市场需求的能力。

全球分子诊断原料市场趋势

在全球分子诊断原料市场，试剂客製化已成为一大趋势，其驱动力来自製造商和实验室对客製化原料配方日益增长的需求。这一趋势强调合作开发，供应商正逐步摆脱标准产品，转而提供包括灵活批量和特定应用混合配方在内的客製化解决方案。增强可追溯性也成为关注的焦点，有助于提高新检测的效率和准确性。因此，原料供应商与诊断试剂开发商之间的策略合作关係日益深化，刺激了研发投入，并推动了创新，以应对不断发展的检测化学和多样化的检体类型。

北美洲
- 我们
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场公司采取的策略
近期市场趋势
企业市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 按细分市场进行企业市占率分析
- 2023-2025年营收年比比较

主要企业简介

Thermo Fisher Scientific
Roche Molecular Diagnostics
Agilent Technologies
Siemens Healthineers
Bio-Rad Laboratories
QIAGEN
PerkinElmer
Illumina
Abbott Molecular
Danaher Corporation
Fujifilm Wako Pure Chemical Corporation
Merck KGaA
Becton, Dickinson and Company
GE Healthcare
Sigma-Aldrich
SeraCare Life Sciences
Pacific Biosciences
Hologic
Genomatix Software GmbH
Spectra Laboratories

结论与建议

简介目录

Product Code: SQMIG35B2280

Global Molecular Diagnostics Raw Material Market size was valued at USD 3.5 Billion in 2024 and is poised to grow from USD 3.8 Billion in 2025 to USD 7.29 Billion by 2033, growing at a CAGR of 8.5% during the forecast period (2026-2033).

The molecular diagnostics raw material market is significantly influenced by the growing demand for accurate and rapid nucleic acid testing, particularly following the heightened awareness during the pandemic. Essential components such as enzymes, oligonucleotides, probes, buffers, and specialty plastics are critical for detecting pathogens and genetic markers. The quality of these inputs directly affects assay sensitivity and compliance, which are vital for patient outcomes and public health responses. The market has evolved from traditional PCR reagents to advanced applications like next-generation sequencing. A key growth factor is the resilience of supply chains and consistent product standards, allowing manufacturers to ensure reliable testing capabilities. This creates opportunities for localized production and innovations such as stabilized reagents, prompting investors to focus on vertical integration and certifications to capitalize on the growing demand.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Molecular Diagnostics Raw Material market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Molecular Diagnostics Raw Material Market Segments Analysis

Global molecular diagnostics raw material market is segmented by product type, technology, application, end user and region. Based on product type, the market is segmented into Nucleic Acids, Primers & Probes, Enzymes, Buffers & Reagents, dNTPs (Deoxynucleotide Triphosphates), Proteins & Antibodies and Others. Based on technology, the market is segmented into PCR (Polymerase Chain Reaction), qPCR / Real-Time PCR, Next-Generation Sequencing (NGS), Microarrays, Isothermal Amplification, CRISPR-based Diagnostics and Others. Based on application, the market is segmented into Infectious Disease Detection, Oncology / Cancer Diagnostics, Genetic Disorder Screening, Pharmacogenomics, Prenatal & Newborn Screening, Companion Diagnostics and Others. Based on end user, the market is segmented into Hospitals & Clinics, Diagnostic Laboratories, Research Institutes, Biopharmaceutical Companies and Academic & Government Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Molecular Diagnostics Raw Material Market

The increasing demand for personalized medicine has significantly heightened the need for a variety of high-quality raw materials used in molecular diagnostics. Tailored diagnostics rely on specific reagents, enzymes, primers, and probes, prompting manufacturers and laboratories to seek reliable components essential for developing and validating companion diagnostics that align with targeted therapies. This necessity drives continuous procurement and inspires suppliers to enhance their capabilities. The demand for consistency, purity, and lot-to-lot reproducibility plays a vital role in market expansion, as it encourages investment in specialized production techniques, quality management systems, and resilient supply chains to adequately address the dynamic needs of clinical applications.

Restraints in the Global Molecular Diagnostics Raw Material Market

The reliance on intricate, globally interconnected supply chains poses significant challenges for the molecular diagnostics raw material market. Disruptions in these networks, along with logistical hurdles and fluctuations in supplier performance, can hinder the consistent availability of essential reagents and components. When manufacturers face issues with sourcing or experience variability in material quality, it can lead to delays in assay development and product launches, ultimately affecting customer trust. Furthermore, the necessity for vendor qualification and regulatory compliance across different regions adds to operational complexities and restricts the ability of manufacturers to expand quickly in response to market demand.

Market Trends of the Global Molecular Diagnostics Raw Material Market

The Global Molecular Diagnostics Raw Material market is witnessing a notable shift towards reagent customization, driven by the growing demand from manufacturers and laboratories for tailored raw material formulations. This trend emphasizes collaborative co-development, where suppliers move away from standard offerings to provide bespoke solutions that include flexible batch sizes and application-specific blends. Enhanced traceability is also becoming a key focus, improving the efficiency and accuracy of novel tests. As a result, strategic partnerships between raw material providers and diagnostic developers are deepening, fostering innovation and driving investments in research and development to keep pace with evolving assay chemistries and diverse sample types.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape
'Value Chain Analysis

Global Molecular Diagnostics Raw Material Market Size by Product Type & CAGR (2026-2033)

Market Overview
Nucleic Acids
Primers & Probes
Enzymes
Buffers & Reagents
dNTPs (Deoxynucleotide Triphosphates)
Proteins & Antibodies
Others

Global Molecular Diagnostics Raw Material Market Size by Technology & CAGR (2026-2033)

Market Overview
PCR (Polymerase Chain Reaction)
qPCR / Real-Time PCR
Next-Generation Sequencing (NGS)
Microarrays
Isothermal Amplification
CRISPR-based Diagnostics
Others

Global Molecular Diagnostics Raw Material Market Size by Application & CAGR (2026-2033)

Market Overview
Infectious Disease Detection
Oncology / Cancer Diagnostics
Genetic Disorder Screening
Pharmacogenomics
Prenatal & Newborn Screening
Companion Diagnostics
Others

Global Molecular Diagnostics Raw Material Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals & Clinics
Diagnostic Laboratories
Research Institutes
Biopharmaceutical Companies
Academic & Government Laboratories

Global Molecular Diagnostics Raw Material Market Size & CAGR (2026-2033)

North America (Product Type, Technology, Application, End User)
- US
- Canada
Europe (Product Type, Technology, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Technology, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Technology, Application, End User)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Technology, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Molecular Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Molecular
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Wako Pure Chemical Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sigma-Aldrich
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SeraCare Life Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pacific Biosciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genomatix Software GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Spectra Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments